Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Apathy in multiple sclerosis: gender matters.
Novo AM, Batista S, Tenente J, Nunes C, Macário C, Sousa L, Gonçalves F. Novo AM, et al. Among authors: nunes c. J Clin Neurosci. 2016 Nov;33:100-104. doi: 10.1016/j.jocn.2016.02.038. Epub 2016 Jul 20. J Clin Neurosci. 2016. PMID: 27448517
The effectiveness of fingolimod in a Portuguese real-world population.
Correia I, Batista S, Marques IB, Sousa M, Ferreira R, Nunes C, Macário MC, Sousa L. Correia I, et al. Among authors: nunes c. Mult Scler Relat Disord. 2016 Mar;6:41-48. doi: 10.1016/j.msard.2016.01.003. Epub 2016 Jan 12. Mult Scler Relat Disord. 2016. PMID: 27063621 Clinical Trial.
Long-term effectiveness and safety of natalizumab in a Portuguese population.
Correia I, Batista S, Galego O, Marques IB, Jesus-Ribeiro J, Martins AI, Nunes C, Macário MC, Cunha L, Sousa L. Correia I, et al. Among authors: nunes c. Int Immunopharmacol. 2017 May;46:105-111. doi: 10.1016/j.intimp.2017.03.006. Epub 2017 Mar 7. Int Immunopharmacol. 2017. PMID: 28282574
Pregnancy in Multiple Sclerosis: A Portuguese cohort study.
Jesus-Ribeiro J, Correia I, Martins AI, Fonseca M, Marques I, Batista S, Nunes C, Macário C, Almeida MC, Sousa L. Jesus-Ribeiro J, et al. Among authors: nunes c. Mult Scler Relat Disord. 2017 Oct;17:63-68. doi: 10.1016/j.msard.2017.07.002. Epub 2017 Jul 3. Mult Scler Relat Disord. 2017. PMID: 29055477
REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal.
Batista S, Nunes CC, Cerqueira JJ, Martins Silva A, Correia de Sá J, Ferreira J, Mendonça MT, Pinheiro J, Salgado V, Correia AS, Sequeira J, Costa A, Sousa L. Batista S, et al. Among authors: nunes cc. Neurol Sci. 2021 May;42(5):1995-2003. doi: 10.1007/s10072-020-04726-6. Epub 2020 Sep 30. Neurol Sci. 2021. PMID: 32997282 Free PMC article.
Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal.
Batista S, Nunes CC, Cerqueira JJ, Silva AM, de Sá JC, Ferreira J, Mendonça MT, Pinheiro J, Salgado V, Correia AS, Sequeira J, Costa A, Sousa L. Batista S, et al. Among authors: nunes cc. Neurol Sci. 2021 Feb;42(2):767. doi: 10.1007/s10072-020-04879-4. Neurol Sci. 2021. PMID: 33165747 Free PMC article. No abstract available.
1,169 results